Vol 91, No 2 (2020)
Clinical vignette
Published online: 2020-02-12

open access

Page views 1534
Article views/downloads 886
Get Citation

Connect on Social Media

Connect on Social Media

Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis

Leszek Gottwald12, Mateusz Pajdzinski2, Wojciech J. Piotrowski3, Sebastian Majewski3, Piotr Sieroszewski4, Jacek Fijuth12
Pubmed: 32083307
Ginekol Pol 2020;91(2):101.


Not available

Article available in PDF format

View PDF Download PDF file


  1. Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3: 17074.
  2. Raghu G, Remy-Jardin M, Myers JL, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5): 44–68.
  3. Fujita J, Obayashi Y, Yamadori I, et al. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor. Respirology. 1998; 3(3): 211–214.
  4. Maher TM, Oballa E, Simpson JK, et al. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017; 5(12): 946–955.
  5. Rusanov V, Kramer MR, Raviv Y, et al. The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation. Chest. 2012; 141(4): 1047–1054.